Reply to: Competing Risk of Mortality May Obscure the True Impact of Smoking on <scp>HCC</scp> in <scp>ACLD</scp>
M Hintersteininger(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Lukas Hartl(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119